IRWD
Ironwood Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

212.47M USD

Market Cap

572.30M USD

Margin of Safety

-169.4%

Intrinsic / Market Ratio

0.37×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

703.26M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

-162.00M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

96.15M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

212.47M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

212.47M USD

from the sum above

Market Cap

572.30M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.37×

the ratio the screener ranks by; Margin of Safety -169.4% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 703.26M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)938.98M USD
−②Net Debt Today318.06M USD
+③Growth Value82.33M USD
=Value703.26M USD

EPV of the Operations (NOPAT over WACC)

938.98M USD

Net debt today

-318.06M USD

Growth Value

+82.33M USD

Value

703.26M USD

①EPV (earnings power value)

938.98M USD

②Net Debt Today

318.06M USD

③Growth Value

82.33M USD

Market value

Market Cap572.30M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+18.6%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): -162.00M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, -162.00M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap572.30M USD

The price on the date above times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 96.15M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF317.84M USD
+②Invested Capital at Year 15, Today96.37M USD
−③Net Debt Today318.06M USD
=Value96.15M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

317.84M USD

②Invested Capital at Year 15, Today

96.37M USD

③Net Debt Today

318.06M USD

Market value

Market Cap572.30M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-495.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 4.59%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.22×Market Risk Premium 6.00%= 5.82%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 46.05M USDPretax Income 70.10M USD= 65.70%

The tax the interest saves.

Interest Expense =EBIT 102.87M USD−Pretax Income 70.10M USD= 32.78M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 32.78M USDTotal Debt 397.26M USD×(1 − Tax Rate for WACC 65.70%)= 2.83%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 397.26M USDMarket Cap + Total Debt 572.30M USD + 397.26M USD= 40.97%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 59.03%×Cost of Equity 5.82%+Debt Weight 40.97%×Cost of Debt 2.83%= 4.59%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 285.41M USD − Total Liabilities 447.42M USD = Book Value Today -162.00M USD

Total Debt 397.26M USD − Cash and Short-Term Investments 79.21M USD = Net Debt Today 318.06M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 15.7%at most 5%does not pass165,239,947 / 156,354,238
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets36.1%at least -10.0%passes(127.17M USD − 24.04M USD) ÷ 285.41M USD
Price to bookMarket Cap ÷ Book Value Today—at most 3×not measured572.30M USD ÷ -162.00M USD
Operating marginOperating Income ÷ Revenue40.1%above 10.0%passes118.88M USD ÷ 296.45M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-15.7%above 10.0%does not pass296.45M USD / 351.76M USD
Net cash(Cash − Total Debt) ÷ Market Cap-55.6%above -30%does not pass(79.21M USD − 397.26M USD) ÷ 572.30M USD
Operating efficiencyOperating Income ÷ Gross Profit—above 25.0%not measured118.88M USD ÷ 0 USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

3.46 USD

Enterprise value

890.36M USD

the provider's own figure

EV / EBITDA

3.74×

Price / book

-3.53×

the provider's book

Price / earnings

4.49×

Return on equity

—

the provider's figure, not this page's

Profit margin

33.4%

Revenue growth

32.6%

Analyst target, mean

6.11 USD

Analysts

4

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

411.01M443.18M351.76M296.45M

Gross profit

411.01M———

Operating income

250.59M168.50M95.81M118.88M

EBITDA

operating income before depreciation and amortisation

261.70M-925.79M100.34M104.76M

Pretax income

252.67M-949.02M65.26M70.10M

Net income

175.24M-1.00B880.88K24.04M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

175.11M-175.68M2.81M39.13M

R&D

44.31M116.20M111.53M95.23M
Balance sheet, year end

Total assets

1.10B471.54M351.26M397.30M

Total liabilities

448.59M818.19M652.90M659.39M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

653.03M-346.64M-301.64M-262.10M

Total debt

416.33M716.25M600.08M598.40M

Cash and equivalents

656.86M92.25M88.65M215.67M

Net PP&E

fixed assets after depreciation

20.33M18.19M15.54M12.76M

Working capital

current assets less current liabilities

755.86M-42.86M143.67M31.99M
Cash flow

Operating cash flow

274.04M183.61M103.65M127.17M

Capital expenditure

paid out, so below zero

-136.14K-273.27K-142.14K-34.03K

Depreciation and amortisation

1.42M1.58M2.01M1.88M

Free cash flow

operating cash flow plus capital expenditure

273.90M183.34M103.51M127.14M